Royalty Pharma poised for biggest US listing of this year
Royalty Pharma will sell $2.2bn of its shares in the biggest US initial public offering
Royalty Pharma will sell $2.2bn of its shares in the biggest US initial public offering
Saudi Arabia is set to unwind the extra production cuts it pledged last month, increasingly
It is a remarkable achievement for a company that reported its first annual operating profit